Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRNX
6476
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $24K | ﹤0.01% |
+1,355
| New | +$25.5K |
|
|
ATMI
6477
CALL
DELISTED
A T M I INC
ATMI
| $24K | ﹤0.01% |
800
+400
| +100% | +$11.4K |
|
|
KEM
6478
DELISTED
KEMET Corporation
KEM
| $24K | ﹤0.01% |
5,007
+808
| +19% | +$4.47K |
|
|
REV
6479
PUT
DELISTED
Revlon, Inc.
REV
| $24K | ﹤0.01% |
1,000
-1,000
| -50% | -$25.5K |
|
|
NMRX
6480
DELISTED
Numerex Corp
NMRX
| $24K | ﹤0.01% |
1,947
+640
| +49% | +$8.05K |
|
|
RNWK
6481
DELISTED
RealNetworks Inc
RNWK
| $24K | ﹤0.01% |
3,380
-6,395
| -65% | -$50.3K |
|
6482
PUT
Aecom
ACM
$9.3B
| $23K | ﹤0.01% |
800
+100
| +14% | +$3.02K |
|
6483
Albany International
AIN
$2.11B
| $23K | ﹤0.01% |
669
-14,024
| -95% | -$501K |
|
6484
CALL
Brookfield
BN
$104B
| $23K | ﹤0.01% |
2,563
-3,417
| -57% | -$31.1K |
|
6485
Burlington
BURL
$23.2B
| $23K | ﹤0.01% |
+732
| New | +$20.5K |
|
6486
First Busey Corp
BUSE
$2.57B
| $23K | ﹤0.01% |
1,506
-184
| -11% | -$3.05K |
|
6487
CALL
Broadwind
BWEN
$93.6M
| $23K | ﹤0.01% |
2,500
-2,900
| -54% | -$22.5K |
|
6488
CALL
Calumet Specialty Products
CLMT
$3.85B
| $23K | ﹤0.01% |
900
-100
| -10% | -$2.79K |
|
6489
Citizens & Northern Corp
CZNC
$456M
| $23K | ﹤0.01% |
1,136
+770
| +210% | +$15.6K |
|
6490
ProShares Trust UltraShort MSCI Emerging Markets
EEV
$2.42M
| $23K | ﹤0.01% |
117
-40
| -25% | -$8.27K |
|
6491
Haverty Furniture Companies
HVT
$397M
| $23K | ﹤0.01% |
747
-14,119
| -95% | -$390K |
|
6492
Kelly Services Class A
KELYA
$514M
| $23K | ﹤0.01% |
928
-12,200
| -93% | -$266K |
|
6493
Standard BioTools
LAB
$340M
| $23K | ﹤0.01% |
605
-345
| -36% | -$10.2K |
|
|
LNW
6494
DELISTED
Light & Wonder
LNW
| $23K | ﹤0.01% |
1,442
-3,324
| -70% | -$58.7K |
|
6495
NWPX Infrastructure Inc
NWPX
$1.19B
| $23K | ﹤0.01% |
599
-952
| -61% | -$34.7K |
|
6496
First Financial Corp
THFF
$958M
| $23K | ﹤0.01% |
623
+512
| +461% | +$17.7K |
|
6497
Universal Logistics Holdings
ULH
$353M
| $23K | ﹤0.01% |
795
-680
| -46% | -$19K |
|
|
HTLF
6498
DELISTED
Heartland Financial USA, Inc.
HTLF
| $23K | ﹤0.01% |
827
+678
| +455% | +$19K |
|
|
SP
6499
DELISTED
SP Plus Corporation
SP
| $23K | ﹤0.01% |
859
+430
| +100% | +$11.1K |
|
|
MFV
6500
DELISTED
MFS SPECIAL VALUE TRUST
MFV
| $23K | ﹤0.01% |
3,292
+1,000
| +44% | +$7.17K |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.88B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.